HomeTELO • CVE
add
Telo Genomics Corp
Previous close
$0.13
Day range
$0.12 - $0.13
Year range
$0.11 - $0.27
Market cap
8.96M CAD
Avg Volume
16.50K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 616.06K | -13.34% |
Net income | -606.06K | 14.75% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -606.19K | 13.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 690.88K | -5.04% |
Total assets | 856.54K | -12.56% |
Total liabilities | 257.05K | 56.96% |
Total equity | 599.49K | — |
Shares outstanding | 71.31M | — |
Price to book | 12.50 | — |
Return on assets | -129.24% | — |
Return on capital | -167.63% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -606.06K | 14.75% |
Cash from operations | -581.77K | 12.49% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -22.50K | — |
Net change in cash | -604.27K | 12.78% |
Free cash flow | -350.75K | 25.17% |
About
Founded
2011
Headquarters
Website
Employees
8